Exchange: NASDAQ·Updated 10:00 AM EDT
TVTX logo

TVTX Travere Therapeutics Inc

$63.25
$0.49
(0.78%)
Today
EarningsOct 29
Mkt Cap$5.92B
Vol42,223.00

About TVTX

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
55

Bullish Sentiment

How do you feel about TVTX?

Advertisement|Remove ads.